Protagenic Therapeutics, Inc. (PTIX) - Latest Market Data

Price & Market Data

Price: $0.209

Daily Change: -$0.0182 / 8.70%

Range: $0.209 - $0.219

Market Cap: $1,710,587

Volume: 1,226

Performance Metrics

1 Week: -21.05%

1 Month: -12.88%

3 Months: -44.36%

6 Months: -58.53%

1 Year: -83.16%

YTD: -53.61%

Company Details

Employees: 3

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Selected stocks

FutureFuel Corp. (FF)

Universe Pharmaceuticals Inc (UPC)

Frontier Group Holdings, Inc. (ULCC)